Brett K. Haumann, Chief Medical Officer at Theravance Biopharma, Inc. (TBPH), sold 29,646 shares at $18.29 ($542K) on 2020-08-21, disclosed to the SEC on 2020-08-24.
Seasonal sale ($542k) by Chief Medical Officer — this insider has traded TBPH in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.22 | 4,646 | $85K | 15.6% |
| 2 | $18.29 | 25,000 | $457K | 84.4% |
| Total | $18.28 avg | 29,646 | $542K | 100% |
| Filing → |
| TBPH | SELL | 2016-08-23 | $266K | — | Filing → |